1. Medication Treatment Consent (Semaglutide/Tirzepatide):
- I understand that I have the right to decline or discontinue treatment at any time and will notify my doctor before doing so.
- I assume responsibility for taking my medication and waive any liability from RenewMe Wellness LLC, Dr. Memon, or any other affiliated provider.
- I have sought the medical services of RenewMe Wellness LLC due to my excess weight or obesity. I have discussed the limited success I have had in losing weight through dieting and exercise alone.
- I understand I will be prescribed medications, including Semaglutide or Tirzepatide.
- I understand that I will need to change my diet, exercise frequency, and behaviors to aid in my long-term weight reduction efforts. I acknowledge that the management of my weight will require lifelong effort, regardless of the method of weight reduction. No drug can provide a quick fix for weight reduction and management.
2. Disclosure of Medical Conditions:
- I have fully disclosed any medical conditions or diseases that may impact my treatment, including but not limited to:
Pregnancy or attempts to become pregnant
Breastfeeding
Gallbladder disease, diabetes, autoimmune diseases, HIV, heart disease, liver disease, kidney disease
Uncontrolled high blood pressure, seizure disorders, blood disorders, anemia, thalassemia, hemophilia
Emphysema, asthma, history of stroke or cancer, multiple endocrine neoplasia Type II, or medullary thyroid carcinoma
- I understand that if I fail to disclose any medical conditions, I release RenewMe Wellness LLC, Dr. Memon, and affiliated providers from any liability associated with my treatment.
3. Understanding of Medication Risks:
- I acknowledge that Semaglutide is 94% similar to natural human glucagon-like peptide 1 (GLP-1), and Tirzepatide is the first dual GIP/GLP-1 receptor co-agonist. Both medications regulate appetite and reduce food intake by decreasing hunger and increasing feelings of fullness.
- For long-term success, I understand that the treatment must be combined with lifestyle changes, including nutritional, exercise, and behavioral habits.
- I understand that the use of Semaglutide/Tirzepatide may expose me to risks, including but not limited to:
Low blood sugar (glucose ≤70 mg/dL), fast heart rate, sweating, shakiness, intense hunger, confusion, nervousness, overstimulation, restlessness, dizziness, insomnia, euphoria, dysphoria, tremor, headache, dry mouth, diarrhea, constipation, other gastrointestinal disturbances, medication allergies, impotence, or changes in libido.
- I further understand that my use of Semaglutide/Tirzepatide may expose me to more serious risks, including:
Pancreatitis, cholelithiasis (gallstones), cholecystitis (gallbladder disease), thyroid disease, changes in heart rate, and dehydration.
4. Safety and Instructions:
- I agree to take Semaglutide/Tirzepatide as prescribed by my doctor and not provide this medication to any other person.
- I will not increase my dosage or combine this medication with any other drug or substance without the recommendation of my doctor.
- I understand that improper use of these medications can lead to serious injury or death.
- If I begin experiencing unusual or unexpected symptoms after starting Semaglutide/Tirzepatide, I will seek immediate medical attention. This may include contacting another qualified physician or going to a hospital emergency room. Symptoms may include but are not limited to: shortness of breath, swelling of hands, legs, or feet (edema), rapid heart palpitations or tachycardia, nervousness, restlessness, insomnia, tremors, rapid breathing, or difficulty tolerating exercise or activity.
5. Off-Label Use Acknowledgment:
- I acknowledge that Semaglutide and/or Tirzepatide may be prescribed for off-label uses. These medications are FDA-approved for specific indications but may be recommended for other purposes.
- I have been informed of the off-label nature of these medications and accept the potential risks, including unknown long-term effects, as discussed with my physician.
6. Seeking Medical Attention:
- If I experience any unusual symptoms, such as shortness of breath, swelling, rapid heart rate, or difficulty tolerating physical activity, I will immediately seek medical help from another qualified physician or go to a hospital emergency room.
7. Medication Use Guidelines:
- I will use Semaglutide/Tirzepatide only as prescribed by my doctor.
- I will not provide this medication to anyone else.
- I understand that improper use or illegal transfer of this medication to another individual can result in serious injury or death.
8. Fees and Refund Policy:
- I understand the fees associated with the weight loss program and agree to fulfill my financial obligations.
- According to FDA Policy Sec. 460.300, I acknowledge that I cannot return or receive refunds for medications and/or injections once dispensed, regardless of effectiveness or possible adverse reactions.
9. Limited Scope of Care:
- I acknowledge that RenewMe Wellness LLC, Dr. Memon, or any affiliated provider supplements my care and does not replace my primary care provider. Responsibility for my overall healthcare should remain with my primary care provider, and I am encouraged to establish or maintain a relationship with one if I do not already have one.
10. Privacy Policy:
- By providing my email address or phone number, I consent to receive unsecured healthcare communications, including appointment reminders, at these contacts.
- I understand that standard text messaging rates or cellular phone charges may apply according to my wireless plan.
11. Telemedicine Consent:
- I authorize RenewMe Wellness LLC to provide healthcare services through telemedicine, which may involve the use of telehealth equipment and communication with providers outside of my physical presence.
- I will ensure I have access to the necessary technology for telemedicine appointments.
- I understand the risks and limitations of telemedicine and consent to its use.
- I agree to verify my identification by showing a valid ID at the beginning of my scheduled appointment.
- I will notify my provider of my location honestly and of any changes before my telehealth visit.
12. Arbitration Agreement:
- In the event a dispute arises over the outcome of this treatment, I consent solely to arbitration as a legal means of settlement.
13. Acknowledgment:
- By signing below, I confirm that I have read and understood the information on this form, and that all the information I have provided is accurate to the best of my knowledge.
- I understand that it is my responsibility to inform RenewMe Wellness LLC, Dr. Memon, or any affiliated provider of any changes to my medical history.
- This consent is ongoing and will remain in effect even after a diagnosis is made and treatment begins.
- I retain the right to discontinue services at any time and to discuss any aspect of my treatment plan with RenewMe Wellness LLC, Dr. Memon, or any affiliated provider.
- I understand that I should not sign this consent form unless I fully understand its contents, as well as the risks and benefits associated with the proposed treatment.
- I agree to release RenewMe Wellness LLC, Dr. Memon, or any affiliated provider from any liability associated with Semaglutide/Tirzepatide treatment.